GBT to Announce Fourth Quarter and Full Year 2021 Financial Results on Wednesday, February 23, 2022
February 16 2022 - 4:05PM
Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today
announced that it will report fourth quarter and full year 2021
financial results on Wednesday, February 23, 2022, after U.S.
financial markets close.
Management will host a conference call on
Wednesday, February 23, 2022, at 4:30 p.m. ET to discuss fourth
quarter and full year 2021 financial results and to provide a
general business update. To participate in the conference call,
please dial 877-407-3982 (domestic) or +1 201-493-6780
(international). A live audio webcast can be accessed on GBT’s
website at www.gbt.com in the Investors section. The archived audio
webcast will be available for one month following the event.
About Global Blood TherapeuticsGlobal Blood
Therapeutics (GBT) is a biopharmaceutical company dedicated to the
discovery, development and delivery of life-changing treatments
that provide hope to underserved patient communities. Founded in
2011, GBT is delivering on its goal to transform the treatment and
care of sickle cell disease (SCD), a lifelong, devastating
inherited blood disorder. The company has introduced Oxbryta®
(voxelotor), the first FDA-approved medicine that directly inhibits
sickle hemoglobin (HbS) polymerization, the root cause of red blood
cell sickling in SCD. GBT is also advancing its pipeline program in
SCD with inclacumab, a P-selectin inhibitor in Phase 3 development
to address pain crises associated with the disease, and GBT021601
(GBT601), the company’s next generation HbS polymerization
inhibitor. In addition, GBT’s drug discovery teams are working on
new targets to develop the next generation of treatments for SCD.
To learn more, please visit www.gbt.com and follow the company on
Twitter @GBT_news.
Contact:Steven Immergut
(media)650-410-3258simmergut@gbt.com
Courtney Roberts (investors)650-351-7881croberts@gbt.com
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Oct 2023 to Oct 2024